Shares of AbbVie Inc. ABBV, +0.29% inched 0.29% higher to $148.53 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX, +0.56% rising 0.56% to 3,828.11 and the Dow Jones Industrial Average DJIA, +1.02% rising 1.02% to 33,160.83. This was the stock’s third consecutive day of gains. AbbVie Inc. closed $27.38 short of its 52-week high ($175.91), which the company reached on April 8th.
The stock underperformed when compared to some of its competitors Tuesday, as Pfizer Inc. PFE, +0.55% rose 0.55% to $47.35, Eli Lilly & Co. LLY, +0.44% rose 0.44% to $366.66, and AstraZeneca PLC ADR AZN, +0.38% rose 0.38% to $61.33. Trading volume (4.6 M) remained 962,159 below its 50-day average volume of 5.6 M.